Working Groups

Active?
Facet Toggle

Working Group on a New Grand Bargain for Antimicrobial Procurement
Amanda Glassman
et al.
June 27, 2022
While there have been high-level commitments from the World Health Assembly, the United Nations General Assembly (UNGA), the G20, and the G7 to tackle AMR, there has yet to be a fundamental change in how we purchase antimicrobials, or an international approach to improving access, fostering innovati...
Innovative Finance for Resettlement Working Group
Cindy Huang
et al.
May 09, 2017
The Innovative Finance for Resettlement Working Group aims to create more and better opportunities for displaced people to be safely resettled in third countries. The Working Group is developing proposals and setting out practical actions for donors and governments to use innovative financing and re...
High Level Panel on Future of Multilateral Development Banking: Exploring a New Policy Agenda
Nancy Birdsall
and
Scott Morris
September 29, 2015
The high level panel will seek to address these fundamental questions as part of an effort to provide a new policy blue print for multilateral development banks, both new and old. Starting with the basic elements of financing and governance first defined 70 years ago, the project will identify what ...
The Future of IDA Working Group
Alan Gelb
et al.
September 15, 2014
Improving Migration Data (May 2008–May 2009)
Devesh Kapur
et al.
September 11, 2014
Drug Resistance Working Group (November 2007 – June 2010)
Amanda Glassman
and
Prashant Yadav
September 10, 2014
Value for Money: An Agenda for Global Health Funding Agencies
Amanda Glassman
et al.
August 25, 2014
As international commitments become more ambitious and aid resources become increasingly constrained, global health funding agencies are seeking to improve the efficiency and impact of their investments. This growing “value for money” (VfM)  agenda aims to reduce costs, increase imp...
Beyond the Fence Study Group
Alan Gelb
et al.
July 10, 2014
The Beyond the Fence Study Group generates rigorous new research to explore how policy decisions on one side of the US-Mexico border ripple to the other side through illicit markets and to inform a policy debate on more bilateral approaches to innovative regulation.